首页 | 本学科首页   官方微博 | 高级检索  
检索        

荜茇宁对高脂血症大鼠血脂代谢及其相关基因表达的影响
引用本文:麻春杰,哈斯阿古拉,张立全,博日吉汗格日勒图,苏日娜.荜茇宁对高脂血症大鼠血脂代谢及其相关基因表达的影响[J].中草药,2008,39(7):1039-1043.
作者姓名:麻春杰  哈斯阿古拉  张立全  博日吉汗格日勒图  苏日娜
作者单位:麻春杰 (内蒙古大学高分子化学及蒙药研究所,内蒙古,呼和浩特,010021); 哈斯阿古拉 (内蒙古大学生物工程中心,内蒙古,呼和浩特,010021); 张立全 (内蒙古大学生物工程中心,内蒙古,呼和浩特,010021); 博日吉汗格日勒图 (内蒙古大学高分子化学及蒙药研究所,内蒙古,呼和浩特,010021); 苏日娜 (内蒙古大学高分子化学及蒙药研究所,内蒙古,呼和浩特,010021);
摘    要:目的 观察荜茇宁对实验性高脂血症大鼠血脂代谢及其相关基因表达的影响.方法 饲喂高脂饲料建立高脂血症大鼠模型,荜茇宁分别按2.5、5、10 mg/kg给大鼠连续ig 4周.实验结束,取空腹血,检测血清总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白Al(ApoAl)、载脂蛋白B(ApoB);利用反转录聚合酶链反应(RT-PCR)测定大鼠肝脏低密度脂蛋白受体(LDLR)、ApoB和3-羟基-3-甲基-戊二酰辅酶A还原酶(HMG-CoAR)mRNA的表达.结果 与模型组相比,荜茇宁能降低血清TC、TG、LDL-C、ApoB水平及ApoB/ApoAl的值(P<0.05),升高HDL-C、ApoAl(P<0.05),能增强高脂血症大鼠LDLR mRNA表达(P<0.05),降低ApoB mRNA表达(P<0.05),但对HMG-CoAR mRNA的影响不明显(P>0.05).结论 荜茇宁具有调节高脂血症大鼠血脂代谢的作用,其机制可能与提高LDLR基因转录水平,降低ApoB mRNA表达有关.

关 键 词:荜茇宁  脂代谢  高脂血症
收稿时间:2007/9/25 0:00:00

Effect of piperlonguminine on blood lipid metabolism and its related genes expression in hyperlipidemia rats
MA Chun-jie,HASI Agul,ZHANG Li-quan,BORIJIHAN Gereltu and Surina.Effect of piperlonguminine on blood lipid metabolism and its related genes expression in hyperlipidemia rats[J].Chinese Traditional and Herbal Drugs,2008,39(7):1039-1043.
Authors:MA Chun-jie  HASI Agul  ZHANG Li-quan  BORIJIHAN Gereltu and Surina
Institution:Institute of Macromolecular Chemistry and Mongolian Medicine, Inner Mongolia University, Huhhot 010021, China;Biotechnology Center, Inner Mongolia University, Huhhot 010021, China;Biotechnology Center, Inner Mongolia University, Huhhot 010021, China;Institute of Macromolecular Chemistry and Mongolian Medicine, Inner Mongolia University, Huhhot 010021, China;Institute of Macromolecular Chemistry and Mongolian Medicine, Inner Mongolia University, Huhhot 010021, China
Abstract:Objective To observe the effects of piperlonguminine on the blood lipid metabolism and its related genes expression in hyperlipidemia rats. Methods The hyperlipidemia models induced by high-fat feeding were established. The piperlonguminine group was fed continuously with piperlonguminine (2.5, 5, and 10 mg/kg) for four weeks. At the last day, all the rats fasted for at least 12 h and the blood was drawn for the measurement of total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), apolipoproteinA1 (ApoA1), and apolipoprotein B (ApoB); The mRNA expression of low density lipoprotein cholesterol receptor (LDLR), ApoB, and 3-hydroxy 3-methylglutaryl co-enzyme A reductase (HMG-CoAR) were measured by RT-PCR. Results Compared with that of the high-fat model group, the serum TC, TG, LDL-C, ApoB levels, and the ratio of ApoB/ApoA1 were reduced (P0.05) and the serum HDL-C and ApoA1 were increased in the piperlonguminine group (P0.05). Piperlonguminine could increase hepatic LDLR mRNA levels (P0.05) and reduce ApoB mRNA levels (P0.05). But it had no significant effects on HMG-CoAR mRNA level (P0.05).Conclusion Piperlonguminine has the effect of regulating lipid metabolism. The mechanism is likely related to increasing LDLR mRNA expression and decreasing ApoB mRNA expression.
Keywords:piperlonguminine  lipid metabolism  hyperlipidemia
本文献已被 万方数据 等数据库收录!
点击此处可从《中草药》浏览原始摘要信息
点击此处可从《中草药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号